MelliCell

MelliCell is an innovative biotechnology company dedicated to discovering and developing advanced treatments for obesity, a precursor to various complications including diabetes. MelliCell approaches adipose tissue as an endocrine organ at the cellular level, aiming to address the root causes of diseases, improve patient outcomes, and advance the field of biotechnology. Our research focuses on unlocking the potential of adipocytes to regulate metabolic processes, offering new solutions to this global health challenge.